Chemotherapy-induced Symptomatic Anaemia
1 clinical trials · Condition
◉ Watch Chemotherapy-induced Symptomatic Anaemia
| Record | Firm | Date |
|---|---|---|
| Biosimilar Retacritâ„¢ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology (NCT01626547) | Hospira, now a wholly owned subsidiary of Pfizer | 2010-12-01 |
Track Chemotherapy-induced Symptomatic Anaemia automatically
Every clearance here is in the API, with alerts when new ones post.